medigraphic.com
Boletín Médico del Hospital Infantil de México

2007, Number 3

<< Back Next >>

Bol Med Hosp Infant Mex 2007; 64 (3)

Attention deficit hyperactivity disorder: a descriptive study in Mexican children attending a psychiatric hospital.

Joffre-Velázquez VM, García-Maldonado G, Martínez-Perales G

Language: Spanish
References: 35
Page: 153-160
PDF size: 166.06 Kb.


ABSTRACT

Introduction. Attention deficit hyperactivity disorder (ADHD) is one of the most frequent causes of consultation in child psychiatry. Objective: To determine the prevalence of the disorder over 4 years, and to establish comorbidity and demographic characteristics.
Materials and methods. Retrospective, descriptive and opened study in a psychiatric hospital by reviewing and directly analyzing the clinical records of paediatric patients attended from January 2003 to December 2006.
Results. The prevalence of the disorder in the period of study was 26.8% (CI of 95% 23.4-30.5%). Male sex was predominant. Oppositional defiant disorder is the more frequent comorbidity, but there are cases with multiple comorbidity. Most parents were married.
Conclusion. The results are similar to previous published results and useful for institutional statistics.


REFERENCES

  1. Hetchaman L, Abikoff H, Klein RG. Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004; 43: 830-8.

  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Text revision. Fourth ed. Washington D.C.: 2000.

  3. Wasserman R, Kelleher K. Identification of attentional and hyperactivity problems in primary care: A report from pediatric research in office settings and the ambulatory sentinel practice network. Pediatrics. 1999; 103: E 38.

  4. Cohen P, Cohen J, Kasen S. An epidemiological study of disorders in late childhood and adolescence. Age and gender specific prevalence. J Child Psychol Psychiatry. 1993; 34: 851-67.

  5. Schahar R, Wachsmuth R. Hyperactivity and parental psychopathology. J Child Psychol Psychiatry. 2000; 31: 381-92.

  6. Barkley R. Impaired delayed responding. A unified theory of attention deficit hyperactivity disorder. En: Routh DK, editor. Disruptive behavior disorders in childhood. New York: Plenum; 1994. p. 11-57.

  7. Jenssen P, Bathara V, Vitiello B, Hoagwood S. Psychoactive medication prescribing practices for U.S. children: Gaps between research and clinical practice. J Am Acad Child Adolesc Psychiatry. 1999; 38: 557-65.

  8. Szatmari P. The epidemiology of attention deficit hyperactivity disorder. Child Adolesc Clin N Am. 1994; 3: 361-72.

  9. Visser M, Lesesne C. Mental health in the United States: Prevalence of diagnosis and medication treatment for attention deficit hyperactivity disorder. United States 2003 (From the Centers for Disease Control and Prevention, Div of Human Development and Disability). JAMA. 2005; 294: 2293-6.

  10. Henggler S, Rowland M. Home-based multisystemic therapy as an alternative to the hospitalization of youth in psychiatric crisis: Clinical outcomes. J Am Acad Child Adolesc Psychiatry. 1999; 38: 1331-9.

  11. Bussing R, Zimma B. Children in special education: Attention of deficit hyperactivity disorder, use of services and unmet need. Am J Public Health. 1999; 88: 1-7.

  12. Caraveo A. Panorama de la investigación clínico epidemiológica en psiquiatría infantil. Psiquiatria. 1994; 10: 84-90.

  13. Caraveo A, Medina–Mora ME, Tapia C, Rascon M. Trastornos psiquiátricos en niños de la República Mexicana. An Inst Mex Psiquiatr. 1992; 3: 56-62.

  14. Macias-Valadéz G. Análisis de las características de un grupo de niños con trastornos por déficit de atención. Salud Publica Mex. 1986; 28: 292-9.

  15. Szatmari L, Offord D. Correlates associated impairments and patterns of services utilization of children with attention deficit disorder: Findings from Ontario Child Health Study. J Child Psychol Psychiatry. 1989; 30: 205-17.

  16. Sidana A, Bathia M. Prevalence and pattern of psychiatric morbidity in children Indian. J Med Sci. 1998; 52: 556-8.

  17. Rowland A, Umbach D, Catoe K, Stallone L. Studying the epidemiology of attention deficit hyperactivity disorder: Screening methods and pilot results. Can J Psychiatry. 2001; 46: 931-40.

  18. Rowland A, Lesesne C, Abramowitz A. The epidemiology of attention-deficit hyperactivity disorder: A public health view. Ment Retard Dev Disabil Res Rev. 2002; 8: 162-70.

  19. Medina–Mora ME, Borges G, Lara C. Prevalencia de trastornos mentales y uso de servicios: Resultados de la encuesta nacional de epidemiología psiquiátrica en México. Salud Mental. 2003; 26: 1-16.

  20. Vasconcelos M, Werner J, Malheiros AF, Lima DF. Attention deficit hyperactivity disorder prevalence in an inner city elementary school. Arq Neuropsiquiatr. 2003; 61: 67-73.

  21. Burd L, Kerbeshian J, Fisher W. Does the use of phenobarbital as an anticonvulsant permanently exacerbate hyperactivity? Can J Psychiatry. 1987; 32: 10-3.

  22. Fristad M, Weller R, Weller E. The Mania Rating Scale (MRS): further reliability and validity studies with children. Ann Clin Psychiatry. 1995; 7: 127-32.

  23. Landman G, McCrindle B. Pediatric management of non pervasively “hyperactive” children. Clin Pediatr. 1986; 25: 600-4.

  24. Biederman J. Sudden death in children treated with a tricyclic antidepressant. J Am Acad Child Adolesc Psychiatry. 1991; 30: 495-8.

  25. Rico D. Detección de problemas de salud mental en escolares. En: Trabajo presentado en reunión científica sobre salud mental. México, D. F.: Instituto Nacional de Salud Mental, DIF; 1992.

  26. Johnston C, Ohan J. Hyperactivity and disruptive behavior disorder. Clin Child Fam Psichol Rev. 2005; 8: 167-82.

  27. Huntin T, Taanila A, Ebeling H. Attention and behavioral problems of Finnish adolescents may be related to the family environment. Eur Child Adolesc Psychiatry. 2005; 14: 471-8.

  28. Keren M, Feldman R, Tyano S. Diagnoses and interactive patterns of infants referred to a community based infant mental health clinic. J Am Acad Child Adolesc Psychiatry. 2001; 40: 27-33.

  29. Eddy L, Toro–Trallero M. Trastorno por déficit de atención con hiperactividad. Estudio para valorar los factores de riesgo, los factores asociados y el estilo educativo de los progenitores. An Esp Pediatr. 1999; 50: 145-50.

  30. Zuvekas S, Talla-Ferro G. Pathways to access health insurance: The health care delivery system and racial/ethnic disparities. Health Aff. 2003; 22: 139-53.

  31. Conners C, Barkley R. Rating scales and checklists for child psychopharmacology. Psychopharmacology Bull. 1985; 21: 809-44.

  32. Wolraich ML, Hanna JN, Pinnock TY, Baumgaertel A. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county wide sample. J Am Acad Child Adolesc Psychiatry. 1996; 35: 319-24.

  33. Angold AE, Costello J, Erkanli A. Comorbidity. J Child Psychol Psychiatry. 1999; 40: 57-87.

  34. Spencer TJ. ADHD and comorbidity in childhood. J Clin Psychiatry. 2006; 67 Supl 8: 27-31.

  35. Johnston C, Mash EJ. Families of children with attention deficit hyperactivity disorder. Review and recommendations of future research. Clin Child Family Psychol. 2001; 4: 183-207.




2020     |     www.medigraphic.com